[Hearing disorders screening in neonates at risk]

T Morlet1, A Moulin, G Putet

  • 1Kresge Hearing Research Laboratory of the South LSU Medical Center, 2020 Gravier Street, New Orleans, LA 70112, USA.

Insights

Early hearing screening for high-risk newborns using otoacoustic emissions and auditory evoked potentials is crucial. This study identified a 0.9% incidence of definite hearing loss, emphasizing the need for continued neonatal hearing assessments.

Area of Science:

  • Neonatal audiology
  • Pediatric hearing screening
  • Otoacoustic emissions and auditory evoked potentials

Background:

  • Neonatal hearing loss affects 1-6 per 1000 live births.
  • Early identification and intervention are critical for language and cognitive development.
  • High-risk neonates require targeted hearing screening protocols.

Purpose of the Study:

  • To evaluate the effectiveness of a multi-stage hearing screening protocol in high-risk neonates.
  • To determine the incidence of definite hearing loss in this population.
  • To assess the diagnostic yield of transient evoked otoacoustic emissions (TEOAE) and brainstem auditory evoked potential (BAEP) tests.

Main Methods:

  • A three-year, eight-month screening of 1,531 high-risk neonates.
  • Two successive transient evoked otoacoustic emissions (TEOAE) recordings.
  • Brainstem auditory evoked potential (BAEP) recording and otolaryngology (ORL) consultation for suspected cases.

Main Results:

  • 11% of neonates were suspected of hearing loss after TEOAE and BAEP testing.
  • 58 infants showed bilateral and 26 unilateral impairment.
  • A 0.9% incidence of definite hearing loss was diagnosed by ORL, with a mean age of diagnosis at 9.9 months.

Conclusions:

  • Early hearing loss screening in at-risk neonates is effective and should be pursued.
  • The implemented protocol successfully identified neonates with hearing impairment.
  • Auditory risk factors are more prevalent in children with hearing loss.

Related Concept Videos